Opdivo Nivolumab 100 Mg 10 Ml Injection

100mg Injection in 1 Vial

4.5 (154)

₹18,000

Opdivo 100mg Injection is an immunotherapy medication used to treat several cancers including non-small cell lung cancer, melanoma, renal cell carcinoma, Hodgkin’s lymphoma, and head and neck squamous cell carcinoma. It works by blocking the PD-1 receptor on T-cells, boosting the immune system’s ability to attack cancer cells. Common side effects include fatigue, nausea, loss of appetite, diarrhea, and skin rashes; infusion reactions can be serious, causing low blood pressure, chills, fever, or breathing difficulty, and should be reported to your doctor immediately.

Description

Introduction Of Opdivo 100mg Injection:

Opdivo 100mg Injection contains Nivolumab, an immune checkpoint inhibitor used in the treatment of advanced melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, and several other advanced cancers.

Opdivo 100mg Injection is administered only by a trained oncologist as a slow intravenous infusion, usually over 60 minutes, given once every 2 to 4 weeks depending on the treatment plan. Your doctor will decide the dose and whether it is used alone or combined with other cancer medicines such as ipilimumab or chemotherapy. It should never be self-administered.

Because this medicine works by activating the immune system, it can sometimes cause the immune system to attack healthy tissues as well. Fatigue, rash, itching, diarrhea, and joint or muscle pain are among the most common effects. Your doctor will monitor you closely for signs of inflammation in the lungs, intestines, liver, kidneys, skin, or hormone glands. Inform your doctor immediately if you notice persistent cough or shortness of breath, severe diarrhea or abdominal pain, yellowing of the skin or eyes, or unusual fatigue.

Uses Of Opdivo 100mg Injection:

  • Advanced Melanoma
  • Non-Small Cell Lung Cancer
  • Renal Cell Carcinoma (Kidney Cancer)
  • Hodgkin Lymphoma
  • Head and Neck Cancer
  • Advanced Gastric, Oesophageal, and Hepatocellular Cancer

Benefits Of Opdivo 100mg Injection:

1. Advanced Melanoma

Melanoma is a serious form of skin cancer that can spread to other organs. Opdivo 100mg Injection, alone or combined with ipilimumab, helps release a natural brake on the immune system, allowing T-cells to recognize and attack melanoma cells more effectively.

2. Non-Small Cell Lung Cancer and Other Cancers

In advanced lung, kidney, head and neck, and certain gastrointestinal cancers, Opdivo 100mg Injection blocks a protein that cancer cells use to switch off the immune system, helping restore the body’s ability to fight the cancer and slow disease progression.

Side effects of Opdivo 100mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Nivolumab:

  • Fatigue
  • Rash
  • Itching
  • Diarrhea
  • Nausea
  • Musculoskeletal pain
  • Cough
  • Shortness of breath
  • Decreased appetite
  • Joint pain
  • Fever

Machanism Of Action Of Opdivo 100mg Injection:

Opdivo Injection contains Nivolumab, a monoclonal antibody that blocks a receptor on T-cells called PD-1. Normally, cancer cells use proteins such as PD-L1 to bind to PD-1 and switch off T-cell activity, helping the tumor evade the immune system. By blocking PD-1, Nivolumab prevents this shutdown, allowing T-cells to remain active and attack the cancer cells.

Contact Us

Info Table
Strength 100 mg
Form Injection
Packaging Type Pack
Composition Nivolumab 100mg
Brand Opdivo 100mg
Packaging Size 10ml
Manufacturer BRISTOL MYERS SQUIBB.
Shelf Life 24 Months
Prescription/Non prescription Non Prescription
Usage Non-small cell lung cancer
Vendor Info
Benefits
Reviews

Description

Introduction Of Opdivo 100mg Injection:

Opdivo 100mg Injection contains Nivolumab, an immune checkpoint inhibitor used in the treatment of advanced melanoma, non-small cell lung cancer, renal cell carcinoma, Hodgkin lymphoma, head and neck cancer, and several other advanced cancers.

Opdivo 100mg Injection is administered only by a trained oncologist as a slow intravenous infusion, usually over 60 minutes, given once every 2 to 4 weeks depending on the treatment plan. Your doctor will decide the dose and whether it is used alone or combined with other cancer medicines such as ipilimumab or chemotherapy. It should never be self-administered.

Because this medicine works by activating the immune system, it can sometimes cause the immune system to attack healthy tissues as well. Fatigue, rash, itching, diarrhea, and joint or muscle pain are among the most common effects. Your doctor will monitor you closely for signs of inflammation in the lungs, intestines, liver, kidneys, skin, or hormone glands. Inform your doctor immediately if you notice persistent cough or shortness of breath, severe diarrhea or abdominal pain, yellowing of the skin or eyes, or unusual fatigue.

Uses Of Opdivo 100mg Injection:

  • Advanced Melanoma
  • Non-Small Cell Lung Cancer
  • Renal Cell Carcinoma (Kidney Cancer)
  • Hodgkin Lymphoma
  • Head and Neck Cancer
  • Advanced Gastric, Oesophageal, and Hepatocellular Cancer

Benefits Of Opdivo 100mg Injection:

1. Advanced Melanoma

Melanoma is a serious form of skin cancer that can spread to other organs. Opdivo 100mg Injection, alone or combined with ipilimumab, helps release a natural brake on the immune system, allowing T-cells to recognize and attack melanoma cells more effectively.

2. Non-Small Cell Lung Cancer and Other Cancers

In advanced lung, kidney, head and neck, and certain gastrointestinal cancers, Opdivo 100mg Injection blocks a protein that cancer cells use to switch off the immune system, helping restore the body’s ability to fight the cancer and slow disease progression.

Side effects of Opdivo 100mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Nivolumab:

  • Fatigue
  • Rash
  • Itching
  • Diarrhea
  • Nausea
  • Musculoskeletal pain
  • Cough
  • Shortness of breath
  • Decreased appetite
  • Joint pain
  • Fever

Machanism Of Action Of Opdivo 100mg Injection:

Opdivo Injection contains Nivolumab, a monoclonal antibody that blocks a receptor on T-cells called PD-1. Normally, cancer cells use proteins such as PD-L1 to bind to PD-1 and switch off T-cell activity, helping the tumor evade the immune system. By blocking PD-1, Nivolumab prevents this shutdown, allowing T-cells to remain active and attack the cancer cells.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Opdivo Nivolumab 100 Mg 10 Ml Injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Opdivo 100mg Injection used for?
Opdivo 100mg Injection (Nivolumab) is an immunotherapy medicine used to treat several cancers, including non-small cell lung cancer, melanoma, renal cell carcinoma, Hodgkin’s lymphoma, and head and neck squamous cell carcinoma.
It’s a monoclonal antibody that blocks the PD-1 receptor on T-cells, which helps boost the immune system’s ability to recognize and attack cancer cells.
Common side effects include fatigue, nausea, loss of appetite, diarrhea, and skin rashes.
Serious infusion reactions can cause low blood pressure, chills, fever, or difficulty breathing — any of these should be reported to your doctor right away.
It’s manufactured by Bristol Myers Squibb, supplied as a 10ml vial, with a 24-month shelf life.
It works by blocking a protein called PD-1 on immune cells, helping the immune system recognize and attack cancer cells, and is used to treat melanoma, lung, kidney, and other cancers. See MedlinePlus Drug Information for more.

Related products